Social media

For the third and final article in our series, ICON’s regulatory expert Jeremy Tinkler discusses ISO 10993-1 in the context of risk estimation. This article looks at the upcoming revision of ISO 10993-1, which has spar...

For the third and final blog in our series, we discuss ISO 10993-1 in the context of risk estimation. This blog looks at the upcoming revision of ISO 10993-1, which has sparked debate but now is in its final draft stag...

Patient recruitment strategies need to evolve to ensure the best data from a wider range of patients. Meet ICON experts at #ASH25, booth \#2161 to learn how our strategic solutions and innovative methods help reduce pati...

On December 8-10 at CVCT, speak with our cardio-metabolic drug development experts about how we’re helping to address the challenges of CV trials and improve outcomes through more efficient trial design, effective use of...

On December 8-10 at CVCT, speak with our cardio-metabolic drug development experts about how we’re helping to address the challenges of CV trials and improve outcomes through more efficient trial design, effective use of...

Join ICON for “Science on Tap” — an evening of discovery, discussion, and holiday cheer! Explore cutting-edge research in precision medicine and bioanalytical laboratory innovation with our expert scientists. If you ar...

Join ICON for “Science on Tap” — an evening of discovery, discussion, and holiday cheer! Explore cutting-edge research in precision medicine and bioanalytical laboratory innovation with our expert scientists. If you ar...

High-risk medical devices and IVDs enter the JCA process in 2026. Are you prepared for what’s next? ICON’s whitepaper outlines what developers need to know—now. Read more: https://ow.ly/2wWF50XgHL8 #MedTech #IVD #JCA #H...

High-risk medical devices and IVDs enter the JCA process in 2026. Are you prepared for what’s next? ICON’s whitepaper outlines what developers need to know—now. Read more: https://ow.ly/2wWF50XgHL8 #MedTech #IVD #JCA #H...

15+ years of healthcare data. Weekly and monthly. Metys®, from Symphony Health, and ICON plc company, gives you unmatched historical depth to track product trends, market shifts, and lifecycle performance with precisio...

15+ years of healthcare data. Weekly and monthly. Metys®, from Symphony Health, and ICON plc company, gives you unmatched historical depth to track product trends, market shifts, and lifecycle performance with precisio...

ICH GCP E6(R3): The Future Starts Now The final version of ICH GCP E6(R3) is here—and it’s changing the way we design and conduct clinical trials. ICON’s regulatory experts will guide you through what’s new, what’s crit...